Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC

NCT05277844 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

106

Enrollment

OTHER_GOV

Sponsor class

Conditions

Oligometastatic Disease
Non-small Cell Lung Cancer
Driver Mutation

Interventions

RADIATION: Local Consolidative Radiation Therapy
DRUG: TKI

Sponsor

Tata Memorial Hospital